Pharmacovigilance and Drug Safety in Oncology

Pharmacovigilance and Drug Safety in Oncology involve the monitoring, assessment, and prevention of adverse effects associated with cancer treatments, including chemotherapy, immunotherapy, targeted therapy, and other oncological drugs. Pharmacovigilance is the science of detecting, evaluating, understanding, and preventing side effects or any other drug-related problems. In oncology, this is particularly important due to the potential severity of side effects and the complex nature of cancer treatments. Ensuring drug safety involves ongoing surveillance, clinical trials, reporting of adverse events, and post-market monitoring to improve treatment outcomes and minimize harm to patients. This field aims to enhance the effectiveness and safety of cancer therapies, providing better care for patients while reducing risks associated with cancer medications.

    Related Conference of Pharmacovigilance and Drug Safety in Oncology

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Pharmacovigilance and Drug Safety in Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in